The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The potential role of serial circulating tumor DNA (ctDNA) testing after upfront surgery to guide adjuvant chemotherapy for early stage pancreatic cancer: The AGITG DYNAMIC-Pancreas trial.
 
Belinda Lee
Honoraria - Roche
Research Funding - AngioDynamics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
Jeanne Tie
Honoraria - Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Haystack Oncology; Illumina; MSD Oncology; Roche; Takeda
Speakers' Bureau - MSD Oncology
 
Yuxuan Wang
Consulting or Advisory Role - Exact Sciences/Thrive Earlier Detection
Patents, Royalties, Other Intellectual Property - U.S. Patent UA2015/0292027: Papanicolaou Test for Ovarian and Endometrial Cancers.; U.S. Patent US2018/0171413: Detection of Tumor-Derived DNA in Cerebrospinal Fluid.; U.S. Patent US2018/0171413: Detection of Tumor-Specific DNA in Saliva and Blood.; U.S. Patent US2018/0258490: Diagnostic Potential of Tumor DNA from Ovarian Cyst Fluid.; U.S. Patent US2018/045669: Methods and Materials for Assessing and Treating Cancer.; U.S. Patent US2018/045669: Methods and Materials for Assessing and Treating Cancer.
 
Joshua D. Cohen
No Relationships to Disclose
 
Jeremy David Shapiro
No Relationships to Disclose
 
Rachel Wong
Consulting or Advisory Role - Bristol Meyers Squibb; Bristol Meyers Squibb; Merck Serono; MSD; MSD; MSD
 
Morteza Aghmesheh
No Relationships to Disclose
 
Andrew Ddembe Kiberu
No Relationships to Disclose
 
Alessandra Francesconi
No Relationships to Disclose
 
Matthew E. Burge
Stock and Other Ownership Interests - coclear; CSL Limited; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Amitesh Chandra Roy
No Relationships to Disclose
 
Lisa Dobbyn
No Relationships to Disclose
 
Janine Ptak
No Relationships to Disclose
 
Natalie Silliman
No Relationships to Disclose
 
Nickolas Papadopoulos
No Relationships to Disclose
 
Kenneth W. Kinzler
Leadership - Haystack Oncology; Thrive Earlier Detection Corp
Stock and Other Ownership Interests - CAGE Pharma; Exact Sciences/Thrive Earlier Detection; Haystack Oncology; ManaT Bio; Neophore; Personal Genome Diagnostics
Consulting or Advisory Role - Cage Pharma; Exact Sciences/Thrive Earlier Detection; Haystack Oncology; ManaT Bio; Neophore; Personal Genome Diagnostics
Patents, Royalties, Other Intellectual Property - I receive royalties for intellectual property owned and managed by Johns Hopkins University.
 
Bert Vogelstein
No Relationships to Disclose
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Roche Molecular Diagnostics (Inst); Servier (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Servier